This topic contains a solution. Click here to go to the answer

Author Question: Individuals who are awaiting trial often spend that time in prison. Indicate whether the ... (Read 40 times)

roselinechinyere27m

  • Hero Member
  • *****
  • Posts: 557
Individuals who are awaiting trial often spend that time in prison.
 
  Indicate whether the statement is true or false

Question 2

Research suggests that those who are processed through mental health court but do not complete it are rearrested at about the same rate as those who went the typical prosecution/conviction/incarceration route.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

fwbard

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

False

Answer to Question 2

True





 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library